SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Wedbush cuts Spyre Therapeutics price target to $120 from $123

Valid market news retained in the public archive without immediate LiveCast distribution.

SYRE

Story updates

12:48:32 PM UTC
SquawkNews
07:48 AM EST, 11/04/2026 (MT Newswires) -- Spyre Therapeutics (SYRE) has an average rating of buy an

Related stories